1 |
Jolobe OMP. Immunoglobulin G4-related disease as the alternative diagnosis. QJM 2021;114:144. [PMID: 33159450 DOI: 10.1093/qjmed/hcaa303] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
2 |
Wang K, Wang Z, Zeng Q, Zhu L, Gao J, Wang Z, Zhang S, Yang F, Shen D, Wang Y, Liu Y. Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis. PLoS One 2021;16:e0245601. [PMID: 33600452 DOI: 10.1371/journal.pone.0245601] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
3 |
Kunimatsu Y, Tani N, Sato I, Ogura Y, Hirose K, Takeda T. IgG4-related lung disease progressing to respiratory failure. Respirol Case Rep 2020;8:e00641. [PMID: 32789018 DOI: 10.1002/rcr2.641] [Reference Citation Analysis]
|
4 |
Le Joncour A, Saadoun D, Cacoub P. La fibrose rétropéritonéale idiopathique. Rev Med Interne 2020;41:822-8. [PMID: 32727694 DOI: 10.1016/j.revmed.2020.06.013] [Reference Citation Analysis]
|
5 |
Kim YJ, Kim GE, Ma SK, Kim SW, Bae EH. Case report: IgG4-related renal disease co-existing with retroperitoneal fibrosis. Transl Androl Urol 2020;9:794-9. [PMID: 32420186 DOI: 10.21037/tau.2020.02.06] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|